Checkpoint Therapeutics, Inc. License Agreements
5 Contracts & Agreements
- SECOND AMENDMENT TO LICENSE AGREEMENT(Amendment # 2) (Filed With SEC on May 10, 2017)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 17, 2017)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 17, 2017)
- Amendment 3 to Exclusive License Agreementbetween Checkpoint Therapeutics, Inc. and Dana-FarberCancer Institute, Inc. (Filed With SEC on March 17, 2017)
- Amendment 2 to Exclusive License Agreementbetween Checkpoint Therapeutics, Inc. and Dana-FarberCancer Institute, Inc. (Filed With SEC on March 17, 2017)